Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -187,443 | -76,375 | -77,372 | -57,428 | -35,615 |
| Depreciation Amortization | 13,279 | 9,747 | 8,780 | 7,004 | 5,733 |
| Accounts receivable | -4,047 | N/A | N/A | N/A | N/A |
| Other Working Capital | 12,130 | 6,849 | -1,966 | -2,365 | -782 |
| Other Operating Activity | 111,779 | 16,691 | 16,963 | 11,939 | 4,235 |
| Operating Cash Flow | $-54,302 | $-43,088 | $-53,595 | $-40,850 | $-26,429 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 48,871 | -45,004 | 78,623 | -94,898 | 15,902 |
| PPE Investments | -20,821 | -5,947 | -4,589 | -17,812 | -3,760 |
| Net Acquisitions | -14,788 | N/A | -3,124 | -387 | N/A |
| Purchase Of Investment | -14,093 | -31,710 | N/A | N/A | N/A |
| Other Investing Activity | -25,298 | 0 | 0 | -3,032 | -163 |
| Investing Cash Flow | $-26,129 | $-82,661 | $70,910 | $-116,129 | $11,979 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 19,957 | N/A | 2,608 | 5,505 | N/A |
| Debt Issued | N/A | 120,900 | N/A | N/A | N/A |
| Common Stock Issued | 1,813 | 94,587 | 1,885 | 147,726 | 6,791 |
| Other Financing Activity | -49,664 | -2,019 | -644 | -241 | 776 |
| Financing Cash Flow | $-27,894 | $213,468 | $3,849 | $152,990 | $7,567 |
| Exchange Rate Effect | N/A | 49 | -54 | -13 | N/A |
| Beginning Cash Position | 121,406 | 33,638 | 12,528 | 16,530 | 23,413 |
| End Cash Position | 13,081 | 121,406 | 33,638 | 12,528 | 16,530 |
| Net Cash Flow | $-108,325 | $87,768 | $21,110 | $-4,002 | $-6,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,302 | -43,088 | -53,595 | -40,850 | -26,429 |
| Capital Expenditure | -20,821 | -5,975 | -4,861 | -17,812 | -3,760 |
| Free Cash Flow | -75,123 | -49,063 | -58,456 | -58,662 | -30,189 |